biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Category

Uncategorized
04
Jan

Scope Fluidics Group’s Bacteromic Receives Conditional Decision on US Patent for BacterOMIC Microfluidic Chip

04.01.2024
Read More
20
Dec

BacterOMIC Secures U.S. Patent for Ultra-Fast Antimicrobial Susceptibility Testing Method and System

20.12.2023
Read More
22
Dec

Scope Fluidics launches Early Access Program for BacterOMIC system

22.12.2023
Read More
17
Nov

Expert Dialogue Forum at Scope Fluidics

17.11.2023
Read More
15
Nov

Bernd Eberhardt Appointed as CEO of Bacteromic, a Scope Fluidics Subsidiary

15.11.2023
Read More
12
Oct

Scope Fluidics workshop about Commercialization of Microfluidics Devices and Systems

12.10.2023
Read More
17
Aug

U.S. Ambassador Mark Brzezinski Visits Scope Fluidics

17.08.2023
Read More
11
Jul

Scope Fluidics team at AACC&DxPx Conference 2023

11.07.2023
Read More
05
Jun

Scope Fluidics publishes BacterOMIC’s operational objectives

05.06.2023
Read More
28
Apr

Most Influencing Person title for prof. Piotr Garstecki

28.04.2023
Read More
1 2 3 4 5 … 12

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home